Global Life Sciences Summit, Session 4A: Unlocking Life Sciences Potential with Generative AI

Discussion on the potential of Generative AI to leverage artificial intelligence algorithms to analyze vast amounts of biological data and generate novel insights, aid in drug discovery by simulating molecular structures and predicting their properties, accelerate the identification of potential drug candidates, and how it can assist in personalized medicine by analyzing patient data to develop tailored treatment plans, leading to breakthroughs in healthcare and disease management.
Guest Speaker: Lana Feng, Co-founder and CEO, Huma.AI
KPMG Host: Joseph Zaccaria, Managing Director, Deal Advisory & Strategy, HCLS